enkephalin, methionine has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonneau, RH; McLaughlin, PJ; Rahn, KA; Turel, AP; Zagon, IS | 1 |
| Donahue, RN; McLaughlin, PJ; Zagon, IS | 1 |
| Campbell, AM; McLaughlin, PJ; Zagon, IS | 1 |
| Jaglowski, JR; Leure-duPree, AE; Manning, JD; McLaughlin, PJ; Stack, BC; Verderame, MF; Zagon, IS | 1 |
| McLaughlin, PJ; Zagon, IS | 1 |
| Benedetti, A; Candelaresi, C; Casini, A; Cautero, N; De Minicis, S; di Francesco, F; Marzioni, M; Risaliti, A; Roskams, T; Saccomano, S; Salzano, R; Svegliati-Baroni, G | 1 |
| Cheng, F; McLaughlin, PJ; Verderame, MF; Zagon, IS | 1 |
| Levin, RJ; McLaughlin, PJ; Wu, Y; Zagon, IS | 1 |
8 other study(ies) available for enkephalin, methionine and Disease Exacerbation
| Article | Year |
|---|---|
Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
Topics: Animals; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Glycoproteins; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neurotransmitter Agents; Peptide Fragments; Receptors, Opioid; Spinal Cord; Time Factors | 2010 |
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice.
Topics: Animals; Apoptosis; Cell Line, Tumor; Disease Progression; DNA; Enkephalin, Methionine; Female; Humans; Mice; Mice, Nude; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Ovarian Neoplasms; Receptors, Opioid; Xenograft Model Antitumor Assays | 2011 |
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Topics: Animals; Behavior, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enkephalin, Methionine; Female; Mice; Mice, Inbred C57BL; Pain Threshold; Spinal Cord | 2012 |
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Carcinoma, Squamous Cell; Cell Proliferation; Disease Progression; Enkephalin, Methionine; Head and Neck Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Survival Analysis | 2005 |
Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Enkephalin, Methionine; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Receptors, Opioid | 2006 |
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.
Topics: Animals; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen Type I; Dimethylnitrosamine; Disease Progression; Enkephalin, Methionine; Hepatocytes; Humans; Liver; Liver Cirrhosis, Experimental; Liver Diseases; Male; Opioid Peptides; Paracrine Communication; Rats; Receptors, Opioid; Signal Transduction | 2008 |
The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.
Topics: Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Disease Progression; Enkephalin, Methionine; Flow Cytometry; Humans; Pancreatic Neoplasms; Receptors, Opioid; Retinoblastoma Protein; RNA, Small Interfering; Signal Transduction; Transfection | 2008 |
Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Cell Division; Cell Movement; Cell Nucleus; Cell Survival; Cytoplasm; Disease Progression; DNA; Enkephalin, Methionine; Epithelium; Female; Fluorescent Antibody Technique, Direct; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Prevalence; Receptors, Opioid; Skin; Survival Rate; Tongue | 1997 |